Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft

International Journal of Medical Sciences

Volumn 6, Issue 5, 2009, Pages 247-252

  Winkler, Heinz ^a  

^a Osteitis Centre   (Austria)

Author keywords

Allograft; Antibiotic; Biofilm; Bone; Hip; Infection; Revision; Uncemented implants

Indexed keywords

ANTIBIOTIC AGENT; ANTIBIOTIC BONE COMPOUND; ANTIBIOTIC LOADED CEMENT; BONE CEMENT; POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG; VANCOMYCIN;

ALLOGRAFT; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BIOFILM; BONE GRAFT; DEBRIDEMENT; HIP ARTHROPLASTY; HUMAN; PROSTHESIS INFECTION; REINFECTION; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 70349919622     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.6.247     Document Type: Review

References (72)

1. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am 1985;67(2):264-273
2. Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005;437:7-11.
3. Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br 2008;90:1580-1584
4. Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 2003;1(4):667-683 (Pubitemid 38855130)
5. Easmon CS. The effect of antibiotics on the intracellular survival of Staphylococcus aureus in vitro. Br J Exp Pathol 1979;60(1):24-28
6. Qazi SN, Harrison SE, Self T, Williams P, Hill PJ. Real-time monitoring of intracellular Staphylococcus aureus replication. J Bacteriol 2004;186(4):1065-1077 (Pubitemid 38209466)
7. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357(7):654-663 (Pubitemid 47267235)
8. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, Gorman SP, Davis RI, Anderson N. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999;37(10):3281-3290 (Pubitemid 29455221)
9. Nelson CL, McLaren AC, McLaren SG, Johnson JW, Smeltzer MS. Is aseptic loosening truly aseptic? Clin Orthop Relat Res 2005;437:25-30.
10. Marrie TJ, Costerton JW. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J Clin Microbiol 1985;22(6):924-933
11. Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, Allan D, Bagg J. Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther 2007;9(3):R46. (Pubitemid 46888032)
12. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, Gorman SP, Davis RI, Anderson N. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999;37(10):3281-3290 (Pubitemid 29455221)
13. Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP. Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery. Antimicrob Agents Chemother 1998;42(11):3002- 3005 (Pubitemid 28501241)
14. Chang CC, Merritt K. Microbial adherence on poly(methyl methacrylate) (PMMA) surfaces. J Biomed Mater Res 1992;26(2):197-207.
15. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351(16):1645-1654
16. von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections. Injury 2006;37 (Suppl 2):S26-33.
17. Neut D, van der Mei HC, Bulstra SK, Busscher HJ. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 2007;78(3):299-308. (Pubitemid 47027135)
18. Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006;50(1):55-61. (Pubitemid 43042902)
19. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001;72(6):557-571 (Pubitemid 34031652)
20. Dunne N, Hill J, McAfee P, Todd K, Kirkpatrick R, Tunney M, Patrick S. In vitro study of the efficacy of acrylic bone cement loaded with supplementary amounts of gentamicin: effect on mechanical properties, antibiotic release, and biofilm formation. Acta Orthop 2007;78(6):774-785
21. El-Azizi M, Rao S, Kanchanapoom T, Khardori N. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 2005;4:2.
22. Fux CA, Wilson S, Stoodley P. Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriol 2004;186(14):4486-4491 (Pubitemid 38891011)
23. Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 2005;57(10):1539-1550
24. Prigge EK. THE TREATMENT OF CHRONIC OSTEOMYELITIS BY THE USE OF MUSCLE TRANSPLANT OR ILIAC GRAFT. J. Bone Joint Surg. Am. 1946;28(3):576-593
25. Greene N, Holtom PD, Warren CA, Ressler RL, Shepherd L, McPherson EJ, Patzakis MJ. In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop 1998;27(3):201-205
26. Masri B, Duncan C, Beauchamp C. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 1998;13(3):331-338 (Pubitemid 28194004)
27. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 2004;53(2):329-334 (Pubitemid 38239970)
28. Walenkamp GH. Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review. J Chemother 2001;13:66-72.
29. Ammon P, Stockley I. Allograft bone in two-stage revision of the hip for infection. Is it safe? J Bone Joint Surg Br 2004;86(7):962-965 (Pubitemid 39255856)
30. Witso E, Persen L, Loseth K, Benum P, Bergh K. Cancellous bone as an antibiotic carrier. Acta Orthop Scand 2000;71(1):80-84
31. Witso E, Persen L, Loseth K, Bergh K. Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics. Acta Orthop Scand 1999;70(3):298-304. (Pubitemid 29327026)
32. Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br 2005;87(3):314-319
33. Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 2000;46(3):423-428
34. Khoo PPC, Michalak KA, Yates PJ, Megson SM, Day RE, Wood DJ. Iontophoresis of antibiotics into segmental allografts. J Bone Joint Surg Br 2006;88:1149-1157
35. Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. J Antimicrob Chemother 2006;58(6):1177-1184 (Pubitemid 44884136)
36. Dunne WMJr., Mason EOJr., Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993;37(12):2522-2526
37. Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 2005;49(6):2467-2473
38. Darouiche RO, Dhir A, Miller AJ, Landon GC, Raad II, Musher DM. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 1994;170(3):720-723 (Pubitemid 24262284)
39. Rose WE, Poppens PT. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother 2009;63(3):485-488
40. Gristina AG, Jennings RA, Naylor PT, Myrvik QN, Webb LX. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother 1989;33(6):813-816 (Pubitemid 19146565)
41. Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009;33(4):374-378
42. Murillo O, Domenech A, Garcia A, Tubau F, Cabellos C, Gudiol F, Ariza J. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2006;50(12):4011-4017 (Pubitemid 44865143)
43. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996;333:245-251 (Pubitemid 26428036)
44. Buttaro MA, Gimenez MI, Greco G, Barcan L, Piccaluga F. High active local levels of vancomycin without nephrotoxicity released from impacted bone allografts in 20 revision hip arthroplasties. Acta Orthop 2005;76(3):336-340 (Pubitemid 41039348)
45. Matzke GR, Zhanel GG, Guay DR. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet 1986;11(4):257-282
46. Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Masse A, Di Perri G. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia. Clin Pharmacokinet 2008;47(12):793-805.
47. Skhirtladze K, Hutschala D, Fleck T, Thalhammer F, Ehrlich M, Vukovich T, Muller M, Tschernko EM. Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother 2006;50(4):1372-1375
48. Deresinski S. Counterpoint: Vancomycin and Staphylococcus aureus--an antibiotic enters obsolescence. Clin Infect Dis 2007;44(12):1543-1548 (Pubitemid 46871499)
49. Watanakunakorn C, Tisone JC. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1982;22(5):903-905 (Pubitemid 13210075)
50. Gonzalez Della Valle A, Bostrom M, Brause B, Harney C, Salvati EA. Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement. Acta Orthop Scand 2001;72(3):237-240 (Pubitemid 32613483)
51. Paprosky WG, Weeden SH, Bowling JW Jr. Component removal in revision total hip arthroplasty. Clin Orthop Relat Res 2001;393:181-193 (Pubitemid 33101712)
52. Lie SA, Havelin LI, Furnes ON, Engesaeter LB, Vollset SE. Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg Br 2004;86(4):504-509
53. Rothman RH, Cohn JC. Cemented versus cementless total hip arthroplasty. A critical review. Clin Orthop 1990;254:153-169
54. Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty 2008;23(8):1232-1238
55. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999;14(3):339-346 (Pubitemid 29172251)
56. Dunne NJ, Hill J, McAfee P, Kirkpatrick R, Patrick S, Tunney M. Incorporation of large amounts of gentamicin sulphate into acrylic bone cement: effect on handling and mechanical properties, antibiotic release, and biofilm formation. Proc Inst Mech Eng [H] 2008;222(3):355-365
57. Neut D, van De Belt H, Stokroos I, van Horn JR, van Der Mei HC, Busscher HJ. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 2001;47(6):885-891 (Pubitemid 32519840)
58. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthop Scand 2000;71(6):625-629
59. Tunney MM, Dunne N, Einarsson G, McDowell A, Kerr A, Patrick S. Biofilm formation by bacteria isolated from retrieved failed prosthetic hip implants in an in vitro model of hip arthroplasty antibiotic prophylaxis. J Orthop Res 2007;25(1):2-10. (Pubitemid 46070726)
60. Jasty M. Jumbo cups and morsalized graft. Orthop Clin North Am 1998;29(2):249-254
61. Obenaus C, Winkler H, Girtler R, Huber M, Schwagerl W. Extra-large press-fit cups without screws for acetabular revision. J Arthroplasty 2003;18(3):271-277 (Pubitemid 36542582)
62. Park DK, Della Valle CJ, Quigley L, Moric M, Rosenberg AG, Galante JO. Revision of the Acetabular Component without Cement. A Concise Follow-up, at Twenty to Twenty-four Years, of a Previous Report. J Bone Joint Surg Am 2009;91(2):350-355
63. Zweymuller KA, Steindl M, Melmer T. Anterior windowing of the femur diaphysis for cement removal in revision surgery. Clin Orthop Relat Res 2005;441:227-236 (Pubitemid 44384226)
64. Stedry V, Dungl P, Hajny P, Biegel M, Podskubka A. [The Zweymuller endoprosthesis in hip joint revision surgery]. Acta Chir Orthop Traumatol Cech 2001;68(4):230-238
65. Schuh A, Werber S, Holzwarth U, Zeiler G. Cementless modular hip revision arthroplasty using the MRP Titan Revision Stem: outcome of 79 hips after an average of 4 years' follow-up. Arch Orthop Trauma Surg 2004;124(5):306-309 (Pubitemid 38931241)
66. Bohm P, Bischel O. [Cement-free diaphyseal fixation principle for hip shaft exchange in large bone defects--analysis of 12 years experience with the Wagner revision shaft]. Z Orthop Ihre Grenzgeb 2001;139(3):229-239
67. Grunig R, Morscher E, Ochsner PE. Three-to 7-year results with the uncemented SL femoral revision prosthesis. Arch Orthop Trauma Surg 1997;116(4):187-197 (Pubitemid 27168311)
68. Lai KA, Shen WJ, Yang CY, Lin RM, Lin CJ, Jou IM. Two-stage cementless revision THR after infection. 5 recurrences in 40 cases followed 2.5-7 years. Acta Orthop Scand 1996;67(4):325-328
69. Younger A, Duncan C, Masri B. Treatment of infection associated with segmental bone loss in the proximal part of the femur in two stages with use of an antibiotic-loaded interval prosthesis. J Bone Joint Surg Am 1998;80(1):60-69 (Pubitemid 28087302)
70. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br 2008;90(2):145-148 (Pubitemid 351303337)
71. Disch AC, Matziolis G, Perka C. Two-stage operative strategy without local antibiotic treatment for infected hip arthroplasty: clinical and radiological outcome. Arch Orthop Trauma Surg 2007;127(8):691-697 (Pubitemid 47304829)
72. Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 2000;381:101-105